The Production Board

WHO WE ARE

We work tirelessly to help build remarkable businesses.

Meet the team »

WHERE WE INVEST

We invest in businesses run by exceptional operators from seed to public markets.

Our businesses »

WHERE WE FOCUS

We specialize in life sciences, food and agriculture, and software.

Areas of focus »

WHO WE ARE

We commercialize scientific breakthroughs and build remarkable consumer brands.

Meet the team »

WHAT WE CREATE

We create value for our employees, investors, customers, future generations, and the planet.

Our business »

WHAT WE PRIORITIZE

We build and invest in businesses that radically increase efficiency production, distribution and health.

Area of focus »

Deep Dive With Us

Listen

Venture Europe: Why "bias to action" and rapid iteration trump being right every single time.

Listen Now »

Listen

Brian Keating's Into the Impossible Series: Dave Friedberg is All-In on Science

Listen Now »

Watch

CNBC: Friedberg lays out 'shock and awe' theory for AI adoption

Watch Now »

Read

Forbes: Latin America is where technology and ag meet

Listen

Full Ratchet: Gene editing, and investing in the future of life sciences with Risa Stack

Listen Now »

Read

CNBC: TPB raises $300 million to save the planet

Listen

Big Tech: Friedberg explains how “faster, cheaper, better” technology will decarbonize Earth

Listen Now »

Watch

BBC HARDtalk: Stephen Sackur speaks to tech investor David Friedberg

Watch Now »

Listen

Where it Happens Feature: Anything is possible with David Friedberg

Listen Now »

Watch

Julia LaRoche: Why free energy will unleash an era of “infinite abundance”

Watch Now »

Read

FrieslandCampina Ingredients and Triplebar Bio Inc. partner to bring cell-based proteins to market

Read

We build and invest in technology businesses
across life sciences, food and agriculture, and software.

Deep Dive With Us

Venture Europe: Why "bias to action" and rapid iteration trump being right every single time.

Brian Keating's Into the Impossible Series: Dave Friedberg is All-In on Science

CNBC: Friedberg lays out 'shock and awe' theory for AI adoption

Forbes: Latin America is where technology and ag meet

Full Ratchet: Gene editing, and investing in the future of life sciences with Risa Stack

CNBC: TPB raises $300 million to save the planet

Big Tech: Friedberg explains how “faster, cheaper, better” technology will decarbonize Earth

BBC HARDtalk: Stephen Sackur speaks to tech investor David Friedberg

Where it Happens Feature: Anything is possible with David Friedberg

Julia LaRoche: Why free energy will unleash an era of “infinite abundance”

FrieslandCampina Ingredients and Triplebar Bio Inc. partner to bring cell-based proteins to market

David Friedberg reflects on 10 years from Climate Corp’s $1bn acquisition

More

Contact

We build and invest in technology businessesacross life sciences, food and agriculture, and software.

Deep Dive With Us

Venture Europe: Why "bias to action" and rapid iteration trump being right every single time.

Brian Keating's Into the Impossible Series: Dave Friedberg is All-In on Science

CNBC: Friedberg lays out 'shock and awe' theory for AI adoption

Forbes: Latin America is where technology and ag meet

Full Ratchet: Gene editing, and investing in the future of life sciences with Risa Stack

CNBC: TPB raises $300 million to save the planet

Big Tech: Friedberg explains how “faster, cheaper, better” technology will decarbonize Earth

BBC HARDtalk: Stephen Sackur speaks to tech investor David Friedberg

Where it Happens Feature: Anything is possible with David Friedberg

Julia LaRoche: Why free energy will unleash an era of “infinite abundance”

FrieslandCampina Ingredients and Triplebar Bio Inc. partner to bring cell-based proteins to market

David Friedberg reflects on 10 years from Climate Corp’s $1bn acquisition

More

Contact

We build and invest in technology businesses
across life sciences, food and agriculture, and software.